Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 19331710)

Published in Int J Technol Assess Health Care on March 31, 2009

Authors

Ron Goeree1, James M Bowen, Gord Blackhouse, Charles Lazzam, Eric Cohen, Maria Chiu, Rob Hopkins, Jean-Eric Tarride, Jack V Tu

Author Affiliations

1: Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. goereer@mcmaster.ca

Articles by these authors

Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med (2006) 10.58

Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet (2006) 6.64

Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA (2003) 6.39

Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA (2002) 6.30

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ (2009) 6.21

Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med (2009) 6.18

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72

A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J (2002) 4.65

Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care (2005) 4.30

Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation (2014) 3.78

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation (2009) 3.55

Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease. J Am Coll Cardiol (2012) 3.45

Effect of socioeconomic status on treatment and mortality after stroke. Stroke (2002) 3.44

Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke (2008) 3.14

Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med (2002) 3.09

Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA (2005) 3.05

Socioeconomic status and mortality after acute myocardial infarction. Ann Intern Med (2006) 3.02

Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation (2012) 2.96

Comparing hierarchical modeling with traditional logistic regression analysis among patients hospitalized with acute myocardial infarction: should we be analyzing cardiovascular outcomes data differently? Am Heart J (2003) 2.88

Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care (2011) 2.87

Impact of hospital nursing care on 30-day mortality for acute medical patients. J Adv Nurs (2007) 2.85

Use of fibrates in the United States and Canada. JAMA (2011) 2.82

Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation (2008) 2.76

Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol (2004) 2.69

Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61

Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation (2003) 2.61

Administrative Data Feedback for Effective Cardiac Treatment: AFFECT, a cluster randomized trial. JAMA (2005) 2.54

Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making (2002) 2.53

Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med (2007) 2.50

Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation (2009) 2.40

Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta (2007) 2.31

The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med (2005) 2.31

Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department. Circulation (2010) 2.29

IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation (2011) 2.29

Sex differences in carotid endarterectomy outcomes: results from the Ontario Carotid Endarterectomy Registry. Stroke (2003) 2.28

Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures. CMAJ (2008) 2.23

The potential economic impact of restricted access to angiotensin-receptor blockers. CMAJ (2011) 2.22

Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors. CMAJ (2009) 2.16

Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol (2007) 2.15

Bundle branch block patterns and long-term outcomes in heart failure. Int J Cardiol (2010) 2.07

Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology (2009) 2.05

Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05

Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care (2013) 2.04

Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario. JAMA (2013) 2.03

Use of niacin in the United States and Canada. JAMA Intern Med (2013) 2.02

Long-term trends in use of and expenditures for cardiovascular medications in Canada. CMAJ (2009) 2.02

Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med (2011) 1.97

The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario. CMAJ (2003) 1.94

Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. EuroIntervention (2009) 1.94

Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J (2008) 1.92

Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail (2012) 1.92

Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007. CMAJ (2010) 1.85

Use of ezetimibe in the United States and Canada. N Engl J Med (2008) 1.85

Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ Heart Fail (2010) 1.83

Temporal trends in the use of percutaneous coronary intervention and coronary artery bypass surgery in New York State and Ontario. Circulation (2010) 1.82

Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med (2012) 1.80

Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies. Circulation (2009) 1.79

Regional differences in process of care and outcomes for older acute myocardial infarction patients in the United States and Ontario, Canada. Circulation (2006) 1.78

Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. Am Heart J (2010) 1.76

Geography and service supply do not explain socioeconomic gradients in angiography use after acute myocardial infarction. CMAJ (2003) 1.76

Impact of the choice of benchmark on the conclusions of hospital report cards. Am Heart J (2004) 1.72

Hospitalization rates and length of stay for cardiovascular conditions in Canada, 1994 to 1999. Can J Cardiol (2003) 1.71

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial. Circulation (2005) 1.71

Emergency department triage of acute myocardial infarction patients and the effect on outcomes. Ann Emerg Med (2009) 1.71

Inpatient smoking-cessation counseling and all-cause mortality in patients with acute myocardial infarction. Am Heart J (2007) 1.69

The identification and development of Canadian coronary artery bypass graft surgery quality indicators. J Thorac Cardiovasc Surg (2005) 1.68

Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used with caution. Med Decis Making (2011) 1.67

The effect of a charted history of depression on emergency department triage and outcomes in patients with acute myocardial infarction. CMAJ (2011) 1.66

Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure. J Card Fail (2003) 1.64

Population rates of cardiac catheterization and yield of high-risk coronary artery disease. CMAJ (2005) 1.64

Time-related mortality for women after coronary artery bypass graft surgery: a population-based study. J Thorac Cardiovasc Surg (2004) 1.62

How many arterial grafts are enough? A population-based study of midterm outcomes. J Thorac Cardiovasc Surg (2006) 1.62

Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction. Eur Heart J (2006) 1.62

Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med (2010) 1.62

Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada. J Am Coll Cardiol (2003) 1.58

Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review. Expert Rev Pharmacoecon Outcomes Res (2014) 1.58

Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J (2007) 1.58

Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol (2011) 1.58

Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care (2006) 1.57

Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol (2007) 1.56

Neighborhood income and stroke care and outcomes. Neurology (2012) 1.56

Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001. Can J Cardiol (2003) 1.56

Relationship between preventability of death after coronary artery bypass graft surgery and all-cause risk-adjusted mortality rates. Circulation (2008) 1.56

Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am J Med (2004) 1.55

Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. Eur Heart J (2012) 1.53

Class effects of statins in elderly patients with congestive heart failure: a population-based analysis. Am Heart J (2007) 1.53

Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada. J Vasc Surg (2008) 1.53

Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation. Can J Ophthalmol (2010) 1.51

Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. CMAJ (2008) 1.51

Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. J Clin Microbiol (2009) 1.51

Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study. BMC Med Res Methodol (2010) 1.50

Public versus private institutional performance reporting: what is mandatory for quality improvement? Am Heart J (2006) 1.50